Characteristics of gastritis in patients with Helicobacter pylori-positive reflux esophagitis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 20, Issue 5, 2005, Pages 682-687

  Mihara, Takafumi ^a   Adachi, Kyoichi ^a   Komazawa, Yoshinori ^a   Yoshida, Manabu ^a   Araki, Asuka ^a   Maruyama, Riruke ^a   Furuta, Kenji ^a   Ishihara, Shunji ^a   Amano, Yuji ^a   Kinoshita, Yoshikazu ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Activity; Duodenal ulcer; Early gastric cancer; Gastric mucosal atrophy; Inflammation; Updated Sydney system

Indexed keywords

ADULT; AGED; DUODENUM ULCER; FEMALE; GASTRITIS; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; REVIEW; SCORING SYSTEM; STOMACH ACID SECRETION; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH CANCER; STOMACH MUCOSA;

EID: 21144447587     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2005.03779.x     Document Type: Review

References (41)

1. Marshall J, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 16: 1311-5.
2. Graham DY. Treatment of peptic ulcers caused by Helicobacter pylori. N. Engl. J. Med. 1993; 328: 349-50.
3. Parsonnet J, Friedman GD, Vandersteen DP et al. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 1991; 325: 1127-31.
4. Isaacson PG, Spencer J. Is gastric lymphoma an infectious disease? Hum. Pathol. 1993; 24: 569-70.
5. Steinbach G, Ford R, Glober G et al. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue: an uncontrolled trial. Ann. Intern. Med. 1999; 131: 88-95.
6. Shirota T, Kusano M, Kawamura O, Horikoshi T, Mori M, Sekiguchi T. Helicobacter pylori infection correlates with severity of reflux esophagitis: with manometry findings. J. Gastroenterol. 1999; 34: 553-9.
7. Koike T, Ohara S, Sekine H et al. Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis. Am. J. Gastroenterol. 1999; 94: 3468-72.
8. Fujishiro H, Adachi K, Kawamura A et al. Influence of Helicobacter pylori infection on the prevalence of reflux esophagitis in Japanese patients. J. Gastroenterol. Hepatol. 2001; 16: 1217-21.
9. Loffeld RJ, Werdmuller BF, Kuster JG, Perez-Perez GI, Blaser MJ, Kuipers EJ. Colonization with cagA-positive Helicobacter pylori strains inversely associated with reflux esophagitis and Barrett's esophagus. Digestion 2000; 62: 95-9.
10. Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997; 112: 1442-7.
11. Fallone CA, Barkun AN, Friedman G et al. Is Helicobacter pylori eradication associated with gastroesophageal reflux disease? Am. J. Gastroenterol. 2000; 95: 914-20.
12. Hamada H, Haruma K, Mihara M et al. High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis. Aliment. Pharmacol. Ther. 2000; 14: 729-35.
13. Sharma P, Vakil N. Review article: Helicobacter pylori and reflux disease. Aliment. Pharmacol. Ther. 2003; 17: 297-305.
14. Dodds WJ, Hogan WJ, Helm JF, Dent J. Pathogenesis of reflux esophagitis. Gastroenterology 1981; 81: 376-94.
15. O'Connor HJ, McGee C, Ghabash NM, Cunnane K. Prevalence of esophagitis in H. pylori-positive peptic ulcer disease and the impact of eradication therapy. Hepatogastroenterology 2001; 48: 1064-8.
16. Malfertheiner P, Dent J, Zeijlon L et al. Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease-results from a randomized trial programme. Aliment. Pharmacol. Ther. 2002; 16: 1431-42.
17. Miwa H, Sugiyama Y, Ohkusa T et al. Improvement of reflux symptoms 3 years after cure of Helicobacter pylori infection: a case-controlled study in the Japanese population. Helicobacter 2002; 7: 219-24.
18. Koike T, Ohara S, Sekine H et al. Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut 2001; 49: 330-4.
19. Moss SF, Calam J. Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori. Gut 1993; 34: 888-92.
20. El-Omar EM, Penman ID, Ardill JE, Chittajallu RS, Howie C, McColl KE. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 1995; 109: 681-91.
21. Lundell LR, Dent J, Bennett JR et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999; 45: 172-80.
22. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma, 2nd English Edition. Gastric Cancer 1998; 1: 10-24.
23. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992; 52: 6735-40.
24. Kimura K, Takemoto T. An endoscopic recognition of the atrophie border and its significance in chronic gastritis. Endoscopy 1969; 3: 87-97.
25. Amano K, Adachi K, Katsube T, Watanabe M, Kinoshita Y. Role of hiatus hernia and gastric mucosal atrophy in the development of reflux esophagitis in the elderly. J. Gastroenterol. Hepatol. 2001; 16: 132-6.
26. Satoh K, Kimura K, Taniguchi Y et al. Distribution of inflammation and atrophy in the stomach of Helicobacter pylori-positive and negative patients with chronic gastritis. Am. J. Gastroenterol. 1996; 91: 963-9.
27. Mihara M, Haruma K, Kamada T et al. The role of endoscopic findings for the diagnosis of Helicobacter pylori infection: evaluation in a country with high prevalence of atrophic gastritis. Helicobacter 1999; 4: 40-8.
28. Miki K, Ichinose M, Shimazu A. Serum pepsinogen as a screening test of extensive chronic gastritis. Gastroenterol. Jpn 1987; 22: 133-41.
29. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston, 1994. Am. J. Surg. Pathol. 1996; 20: 1161-81.
30. Ishihara S, Okuyama T, Ishimura N et al. Intragastric distribution of Helicobacter pylori during short-term omeprazole therapy: study using Carnoy's fixation and immunohistochemistry for detection of bacteria. Aliment. Pharmacol. Ther. 2001; 15: 1485-91.
31. Gutierrez O, Melo M, Segura AM, Angel A, Genta RM, Graham DY. Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis. Scand. J. Gastroenterol. 1997; 32: 664-8.
32. Haruma K, Mihara M, Okamoto E et al. Eradication of Helicobacter pylori increases gastric acidity in patients with atrophic gastritis of the corpus - evaluation of 24-h pH monitoring. Aliment. Pharmacol. Ther. 1999; 13: 155-62.
33. Jang TJ, Kim NI, Suh JI, Yang CH. Reflux esophagitis facilitates low Helicobacter pylori infection rate and gastric inflammation. J. Gastroenterol. Hepatol. 2002; 17: 839-43.
34. Vicari JJ, Peek RM, Falk GW et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 1998; 115: 50-7.
35. + Helicobacter pylori in reflux oesophagitis. Gut 2001; 49: 341-6.
36. Wu JC, Chan FK, Ching JY et al. Effect of Helicobacter pylori eradication on treatment of gastro-oesophageal reflux disease: a double blind, placebo controlled, randomised trial. Gut 2004; 53: 174-9.
37. Shimoyama T, Fukuda S, Tanaka M, Mikami T, Saito Y, Munakata A. High prevalence of the CagA-positive Helicobacter pylori strains in Japanese asymptomatic patients and gastric cancer patients. Scand. J. Gastroenterol. 1997; 32: 465-8.
38. El-Omar EM, Carrington M, Chow WH. et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398-402
39. correction published in Nature 2001; 412: 99.
40. Furuta T, El-Omar EM, Xiao F et al. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 2002; 123: 92-105.
41. Adachi K, Fujishiro H, Katsube T et al. Predominant nocturnal acid reflux in patients with Los Angeles grade C and D reflux esophagitis. J. Gastroenterol. Hepatol. 2001; 16: 1191-6.